Literature DB >> 32815500

Malaria Risk and Prevention in Asian Migrants to Angola.

José Franco Martins1, Cátia Marques2, Benjamin Nieto-Andrade2, Julia Kelley3, Dhruviben Patel3, Doug Nace3, Camelia Herman3, Joel Barratt3, Gabriel Ponce de León4,3, Eldin Talundzic3, Eric Rogier3, Eric S Halsey4,3, Mateusz M Plucinski3,4.   

Abstract

The number of Asian migrants working in sub-Saharan developing countries like Angola has been increasing. Their malaria risk, prevention, and care-seeking practices have not been characterized. A cross-sectional survey was conducted in 733 Chinese and Southeast Asian migrants in Angola. Respondents were interviewed and provided blood samples. Samples were analyzed to detect Plasmodium antigen and characterize host anti-Plasmodium response. Positive samples were genotyped using the pfs47 marker. Most respondents (72%; 95% CI: 68-75) reported using bed nets, but less than 1% reported using chemoprophylaxis. Depending on the assay, 1-4% of respondents had evidence of active malaria infection. By contrast, 55% (95% CI: 52-59) were seropositive for Plasmodium antibodies. Most infections were Plasmodium falciparum, but infection and/or exposure to Plasmodium vivax and Plasmodium malariae was also detected. Seroprevalence by time in Angola showed most exposure occurred locally. One respondent had sufficiently high parasitemia for pfs47 genotyping, which showed that the infection was likely locally acquired despite recent travel to home country. Asian migrants to Angola are at substantial risk of malaria. Employers should consider enhanced malaria prevention programs, including chemoprophylaxis; embassies should encourage prevention practices. Angolan healthcare workers should be aware of high malaria exposure in Asian migrants.

Entities:  

Mesh:

Year:  2020        PMID: 32815500      PMCID: PMC7646810          DOI: 10.4269/ajtmh.20-0706

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  38 in total

1.  Knowledge, attitudes, and practices on malaria prevention among Chinese international travelers.

Authors:  Min Zhang; Zhiyong Liu; Hongtao He; Lan Luo; Shunqing Wang; Honglei Bu; Xian Zhou
Journal:  J Travel Med       Date:  2011-04-06       Impact factor: 8.490

2.  Evaluation of antimalarial resistance marker polymorphism in returned migrant workers in China.

Authors:  Jun Feng; Jun Li; He Yan; Xinyu Feng; Zhigui Xia
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

3.  Rift Valley fever virus imported into China from Angola.

Authors:  Wei Liu; Fu-Jun Sun; Yi-Gang Tong; Shi-Qing Zhang; Wu-Chun Cao
Journal:  Lancet Infect Dis       Date:  2016-11       Impact factor: 25.071

4.  Next-Generation Sequencing and Bioinformatics Protocol for Malaria Drug Resistance Marker Surveillance.

Authors:  Eldin Talundzic; Shashidhar Ravishankar; Julia Kelley; Dhruviben Patel; Mateusz Plucinski; Sarah Schmedes; Dragan Ljolje; Brooke Clemons; Susan Madison-Antenucci; Paul M Arguin; Naomi W Lucchi; Fredrik Vannberg; Venkatachalam Udhayakumar
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

5.  Screening for Pfhrp2/3-Deleted Plasmodium falciparum, Non-falciparum, and Low-Density Malaria Infections by a Multiplex Antigen Assay.

Authors:  Mateusz M Plucinski; Camelia Herman; Sophie Jones; Rafael Dimbu; Filomeno Fortes; Dragan Ljolje; Naomi Lucchi; Sean C Murphy; Nahum T Smith; Kurtis R Cruz; Annette M Seilie; Eric S Halsey; Venkatachalam Udhayakumar; Michael Aidoo; Eric Rogier
Journal:  J Infect Dis       Date:  2019-01-09       Impact factor: 5.226

6.  Severe Malaria Not Responsive to Artemisinin Derivatives in Man Returning from Angola to Vietnam.

Authors:  Pascal Ringwald; Arjen M Dondorp
Journal:  Emerg Infect Dis       Date:  2015-07       Impact factor: 6.883

7.  Severe Malaria Not Responsive to Artemisinin Derivatives in Man Returning from Angola to Vietnam.

Authors:  Nguyen Van Hong; Alfred Amambua-Ngwa; Nguyen Quang Tuan; Do Duy Cuong; Nguyen Thi Huong Giang; Nguyen Van Dung; Ta Thi Tinh; Nguyen Van Tien; Bui Quang Phuc; Tran Thanh Duong; Anna Rosanas-Urgell; Jean-Pierre Van Geertruyden; Umberto D'Alessandro; Annette Erhart
Journal:  Emerg Infect Dis       Date:  2015-07       Impact factor: 6.883

8.  Polymorphisms of Plasmodium falciparum k13-propeller gene among migrant workers returning to Henan Province, China from Africa.

Authors:  Chengyun Yang; Hongwei Zhang; Ruimin Zhou; Dan Qian; Ying Liu; Yuling Zhao; Suhua Li; Bianli Xu
Journal:  BMC Infect Dis       Date:  2017-08-10       Impact factor: 3.090

9.  Infectious disease implications of large-scale migration of Venezuelan nationals.

Authors:  Ashleigh R Tuite; Andrea Thomas-Bachli; Hernan Acosta; Deepit Bhatia; Carmen Huber; Kieran Petrasek; Alexander Watts; Jean H E Yong; Isaac I Bogoch; Kamran Khan
Journal:  J Travel Med       Date:  2018-01-01       Impact factor: 8.490

10.  Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017.

Authors:  Elizabeth Davlantes; Pedro Rafael Dimbu; Carolina Miguel Ferreira; Maria Florinda Joao; Dilunvuidi Pode; Jacinto Félix; Edgar Sanhangala; Benjamin Nieto Andrade; Samaly Dos Santos Souza; Eldin Talundzic; Venkatachalam Udhayakumar; Chantelle Owens; Eliane Mbounga; Lubbe Wiesner; Eric S Halsey; José Franco Martins; Filomeno Fortes; Mateusz M Plucinski
Journal:  Malar J       Date:  2018-04-03       Impact factor: 2.979

View more
  2 in total

1.  Antibody dynamics in children with first or repeat Plasmodium falciparum infections.

Authors:  Eric Rogier; Doug Nace; Pedro R Dimbu; Brian Wakeman; James G Beeson; Chris Drakeley; Kevin Tetteh; Mateusz Plucinski
Journal:  Front Med (Lausanne)       Date:  2022-07-19

2.  Access, utilization, and barriers to using malaria protection tools in migrants to Iran.

Authors:  Hassan Okati-Aliabad; Alireza Ansari-Moghaddam; Mahdi Mohammadi; Jalil Nejati; Mansour Ranjbar; Ahmad Raeisi; Goodarz Kolifarhood; Fariba Shahraki-Sanavi; Alireza Khorram
Journal:  BMC Public Health       Date:  2022-08-25       Impact factor: 4.135

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.